Golden State Medical Supply recall: Carbamazepine Tablets
Golden State Medical Supply Inc. is recalling Carbamazepine Tablets because of manufacturing-practice violations – 1200 bottles. The U.S. Food and Drug Administration published the recall on August 26, 2026; it began on August 7, 2026. Distributed nationwide.
Serious Class II means the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.

Share
| Product | Carbamazepine Tablets |
| Brand | Golden State Medical Supply |
| Company | Golden State Medical Supply Inc. |
| Type | Drugs |
| Classification | Class II |
| Recall date | August 7, 2026 |
| Published by FDA | August 26, 2026 |
| Quantity | 1200 bottles |
| Recall ID | 99614 |
Recalled products
- Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
- FDA recall number
- D-0771-2026
- Codes, lots and dates
- Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Quantity
- 1200 bottles
- Classification
- Class II
Identifiers and details
- FDA event ID
- 99614
- Initiated
- Voluntary: Firm initiated
- Status
- Ongoing
- Firm location
- Camarillo, CA, United States
Why it was recalled
The problem: manufacturing-practice violations.
The reason the FDA lists: “CGMP deviations: tablets with black specks.”
Where it was sold
Nationwide. Distribution as the FDA records it: “USA Nationwide”
What to do
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Official notice: FDA Enforcement Report record (event 99614, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.
Other Golden State Medical Supply recalls
| Date | Recall | Problem | Agency |
|---|---|---|---|
| Sep 9, 2026 | Failed Dissolution Specifications. Notification from the manufacturer that lot is being re… Serious | FDA Class II |
Other drug recalls
| Date | Recall | Problem | Agency |
|---|---|---|---|
| Oct 7, 2026 | Failed Dissolution Specifications: below specification Serious | FDA Class II | |
| Oct 7, 2026 | Crystallization Serious | FDA Class II | |
| Oct 7, 2026 | Failed dissolution specifications. Serious | FDA Class II | |
| Oct 7, 2026 | Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient ou… Serious | FDA Class II | |
| Oct 7, 2026 | a sterility problem Serious | FDA Class II | |
| Oct 7, 2026 | Defective Container; packets were found to be either empty or partially full. Serious | FDA Class II |
About this recall
Is Golden State Medical Supply Carbamazepine Tablets recalled?
Yes. Golden State Medical Supply Inc. recalled it on August 7, 2026; FDA published it August 26, 2026 (Class II). Only the lots, dates or models listed on this page are included.
Why was it recalled?
Because of manufacturing-practice violations. The reason given: CGMP deviations: tablets with black specks.
What should I do if I have it?
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Where was it sold?
Nationwide.
More recalls
Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.